Each day, the Benzinga Pro news team highlights several stocks with Trading Idea potential. Be the first to see them by becoming a Benzinga Pro user!
Netflix, Inc. (NASDAQ: NFLX) stock was trading higher by more than 1 percent early Monday morning. The company is scheduled to report its first quarter results after market close and is expected to earn 64 cents per share on revenue of $3.69 billion.
Bank of America Corp (NYSE: BAC) was trading higher by nearly 1 percent after the Wall Street giant reported its first quarter results. The company said it earned 62 cents per share in the first quarter on revenue of $23.06 billion versus expectations of 59 cents per share and $23.1 billion. As a reminder, big bank stocks traded lower on Friday after a handful of big bank peers reported their earnings.
Navistar International Corp (NYSE: NAV) was trading higher by more than 6 percent in reaction to a Wall Street Journal report that Volkswagen's (OTC: VLKAY) commercial-vehicles business is evaluating a takeover of the American-based truck maker.
Dynavax Technologies Corporation (NASDAQ: DVAX) gained more than 12 percent early in reaction to reports of favorable comments from a Wall Street analyst. According to reports, JPMorgan commented that Dynavax should gain more than 35 percent from current levels in reaction to a favorable results from an initial 1b/2 trial of SD-101 + Pembro.
Apricus Biosciences Inc (NASDAQ: APRI) lost nearly 10 percent early Monday morning. The urology and rheumatology focused biopharmaceutical company said the FDA recommended the company reformulates its Vitaros therapy. Specifically, the FDA is recommending the company "develop a new Vitaros formulation that reduces the concentration of DDAIP.HCl from 2.5% to 0.5% in order to address the tumor promotion and partner transference safety concerns."
A Peek Into The Markets: US Stock Futures Rise Ahead of Bank of America Earnings
Economic Data Scheduled For Monday
See more from Benzinga
- Analyst: Muted Expectations For IBM Heading Into Q1 Earnings
- 4 Reasons Why TechnipFMC Was Upgraded By Goldman Sachs
© 2018 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.